BP-897
BP-897 is a synthetic compound that acts as a selective dopamine receptor D3 partial agonist. It has been primarily researched for its potential therapeutic effects in the treatment of drug addiction, particularly cocaine addiction.
Pharmacology
BP-897 exhibits high affinity and selectivity for the dopamine receptor D3 subtype, which is predominantly expressed in the limbic system of the brain. This region is associated with the regulation of emotion and reward, making D3 receptors a target for addressing addictive behaviors. By partially activating these receptors, BP-897 is thought to modulate the dopaminergic system and reduce the reinforcing effects of addictive substances.
Research and Development
Initial studies on BP-897 have shown promising results in animal models of addiction. Research indicates that BP-897 can reduce self-administration of cocaine in rodents, suggesting its potential as a treatment for cocaine dependence. Further studies are needed to evaluate its efficacy and safety in humans.
Mechanism of Action
BP-897's mechanism of action involves partial agonism at the D3 receptor, which means it activates the receptor to a lesser degree than the endogenous ligand, dopamine. This partial activation is believed to help normalize the dopaminergic signaling in the brain, which is often dysregulated in individuals with substance use disorders.
Potential Therapeutic Uses
While the primary focus of BP-897 research has been on cocaine addiction, its selective action on D3 receptors suggests it may have broader applications in treating other forms of addiction and possibly neuropsychiatric disorders where the dopaminergic system is implicated.
Side Effects and Safety
As BP-897 is still under investigation, comprehensive data on its side effects and long-term safety profile are not yet available. Preliminary studies have not reported significant adverse effects, but further clinical trials are necessary to establish its safety in humans.
See Also
References
External Links
-
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD